Affinity of Rimantadine Enantiomers against Influenza A/M2 Protein Revisited

ACS Medicinal Chemistry Letters
2017.0

Abstract

Recent findings from solid state NMR (ssNMR) studies suggested that the (<i>R</i>)-enantiomer of rimantadine binds to the full M2 protein with higher affinity than the (<i>S</i>)-enantiomer. Intrigued by these findings, we applied functional assays, such as antiviral assay and electrophysiology (EP), to evaluate the binding affinity of rimantadine enantiomers to the M2 protein channel. Unexpectedly, no significant difference was found between the two enantiomers. Our experimental data based on the full M2 protein function were further supported by alchemical free energy calculations and isothermal titration calorimetry (ITC) allowing an evaluation of the binding affinity of rimantadine enantiomers to the M2TM pore. Both enantiomers have similar channel blockage, affinity, and antiviral potency.

Knowledge Graph

Similar Paper

Affinity of Rimantadine Enantiomers against Influenza A/M2 Protein Revisited
ACS Medicinal Chemistry Letters 2017.0
Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants
ACS Medicinal Chemistry Letters 2018.0
Binding and Proton Blockage by Amantadine Variants of the Influenza M2<sub>WT</sub> and M2<sub>S31N</sub> Explained
Journal of Medicinal Chemistry 2017.0
Aminoadamantanes with Persistent in Vitro Efficacy against H1N1 (2009) Influenza A
Journal of Medicinal Chemistry 2014.0
Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-Docking using a pore blocking model
Bioorganic &amp; Medicinal Chemistry Letters 2010.0
Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling
Bioorganic &amp; Medicinal Chemistry Letters 1999.0
Exploring the Size Limit of Templates for Inhibitors of the M2 Ion Channel of Influenza A Virus
Journal of Medicinal Chemistry 2011.0
Molecular basis of the selective binding of MDMA enantiomers to the alpha4beta2 nicotinic receptor subtype: Synthesis, pharmacological evaluation and mechanistic studies
European Journal of Medicinal Chemistry 2014.0
2-(Alkyl/Aryl)Amino-6-Benzylpyrimidin-4(3H)-ones as Inhibitors of Wild-Type and Mutant HIV-1: Enantioselectivity Studies
Journal of Medicinal Chemistry 2012.0
Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus
Journal of Medicinal Chemistry 2017.0